Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Alignment Healthcare, Inc. (NASDAQ: ALHC) earns capitation revenue or manages its medical loss ratio can mean sifting through hundreds of SEC pages. Complex items鈥擟MS risk-adjustment methodology, provider network agreements, or value-based care metrics鈥攐ften hide in footnotes. Stock Titan鈥檚 AI-powered summaries turn those dense disclosures into plain-English insights, so you see the numbers and the nuance without scanning every line.
Whether you need an Alignment Healthcare annual report 10-K simplified or the latest Alignment Healthcare quarterly earnings report 10-Q filing, this page delivers every document the moment it hits EDGAR. Our platform automatically tags material events, making the next Alignment Healthcare 8-K material events explained easy to spot. AG真人官方-time alerts highlight Alignment Healthcare insider trading Form 4 transactions and send instant notifications when executives buy or sell shares鈥攊deal for monitoring Alignment Healthcare executive stock transactions Form 4.
Here鈥檚 how professionals use these filings:
- Compare member growth trends quarter-over-quarter without wading through actuarial tables.
- Review risk-score disclosures before earnings calls using our AI commentaries.
- Evaluate leadership incentives with the Alignment Healthcare proxy statement executive compensation section pre-highlighted.
Every form鈥�10-K, 10-Q, 8-K, S-1, and more鈥攊s indexed, and AI-powered summaries explain filing meanings in simple terms. Need to dive deeper? Open the full document alongside side-by-side analytics that clarify revenue recognition or contract liabilities. From Alignment Healthcare earnings report filing analysis to understanding Alignment Healthcare SEC documents with AI, you鈥檒l find what matters faster, make informed decisions sooner, and never miss another Alignment Healthcare Form 4 insider transactions real-time update.
Alignment Healthcare (ALHC) Form 144 summary: The filing notifies a proposed sale of 18,600 shares of common stock on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $269,886. The filing reports 198,031,417 shares outstanding. The shares were acquired on 03/26/2021 as pre-IPO shares issued in exchange for partnership units. The filing lists an approximate date of sale of 08/11/2025 and states there were no securities sold in the past three months. By signing the notice the seller represents they do not know of any undisclosed material adverse information about the issuer.
FMR LLC (parent of Fidelity Investments) and its chair Abigail P. Johnson filed Amendment No. 4 to Schedule 13G reporting a passive stake in Alignment Healthcare (ALHC).
- Shares owned: 11,279,800.70 common shares.
- Percent of class: 5.7 % as of the event date 30 Jun 2025.
- Voting power: FMR holds sole voting power over 11,277,456.23 shares; Johnson reports no direct voting power.
- Dispositive power: FMR and Johnson each have sole dispositive power over the full 11.28 m shares; no shared powers are disclosed.
The filing is made under Rule 13d-1(b)/(c), confirming the stake is held in the ordinary course of business with no intent to influence control. The signature is dated 5 Aug 2025 and executed by Richard Bourgelas under existing power of attorney.
Crossing the 5 % threshold positions Fidelity as a significant institutional shareholder, potentially broadening ALHC鈥檚 investor base and adding passive support to the stock鈥檚 float; however, the filing provides no insight into future trading intentions.
Form 4 filing for Alignment Healthcare (ALHC) shows Director Joseph S. Konowiecki sold 25,000 common shares on 31 Jul 2025 at $16.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted 5 Mar 2025. Gross proceeds equal roughly $400k.
Following the sale, Konowiecki鈥檚 direct ownership stands at 1,152,049 shares. No derivative securities were reported. The transaction does not alter board status and no other insider activity is disclosed in this filing.
Alignment Healthcare, Inc. (ALHC) 鈥� Form 144 filing
An insider intends to sell up to 25,000 common shares (鈮�0.013% of the 198,031,417 shares outstanding) through broker Justin Tabit on or about 31 Jul 2025. The shares, valued at an estimated $398,750, were originally received on 6 Oct 2014 as equity awards from Joseph Konowiecki. No related sales have been made in the past three months. The filer confirms possession of no undisclosed material adverse information and notes potential reliance on a Rule 10b5-1 trading plan.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
